By Next PharmaceuticalNEXT Pharma recently hosted insightful awareness sessions focusing on Obeticholic Acid (OCA), a crucial medication used in the management of primary biliary cholangitis (PBC).
These sessions aimed to educate healthcare professionals on the therapeutic benefits of OCA, its mechanism of action as a farnesoid X receptor (FXR) agonist, and its role in improving liver function in patients who have not responded adequately to conventional therapies.
Discussions likely covered the importance of early diagnosis of PBC, proper patient selection for OCA treatment, and managing potential side effects to optimize patient outcomes in the ongoing effort to enhance liver health in Pakistan.
The awareness sessions were conducted at Nishtar Hospital, Multan; Gulab Devi Hospital, Lahore; Government General Hospital, Faisalabad.
3 Replies to “NEXT Pharma Session Spotlights Obeticholic Acid for PBC Awareness”
Steven Rich, May 29, 2024
How all this mistaken idea of denouncing pleasure and praising pain was born and
I will give you a complete account of the system.
Maria Taylor, May 29, 2024
Except to obtain some advantage from it but who has any right to find fault undertakes laborious physical exercise.
William Cobus, May 29, 2024
Undertakes laborious physical exercise, except to obtain some advantage from
it but who has any right to find fault.
Comments are closed.